Umbilical Cord-Derived Mesenchymal Stem Cells Infusion In Type 2 Diabetes Mellitus Patients: A Retrospective Cytopeutics’ Registry Study Read More »
Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy. Read More »
Autologous MSC infusion improves ejection fraction and wall thickness in severe ischemic cardiomyopathy: Results from a clinical multicenter phase ll/lll randomized controlled trial. Read More »
Improved cells survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Read More »
Mesenchymal stromal cells (cyto-msc) are well-tolerated and associated with renal function improvement in patients with chronic kidney disease: an observational retrospective study Read More »
The Effects Of Intravenous Infusion Of Autologous Mesenchymal Stromal Cells In Patients With Subacute Middle Cerebral Artery Infarct: A Phase 2 Randomized Controlled Trial On Safety, Tolerability And Efficacy Read More »
BM-MCS Accelerates Acute Stroke Recovery In A Randomized Placebo-controlled Clinical Phase Ii/iii Study Read More »
Allogenic cord-derived MSC infusion is safe and improves metabolic functions of uncontrolled diabetes patients. Read More »
High Dose Of Intravenous Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (Clv-100) Infusion Displays Better Immunomodulatory Effect Among Healthy Volunteers: A Phase 1 Clinical Study Read More »
Autologous bone marrow mesenchymal stromal cells can treat arthritic joints of rheumatoid arthritis patients: Reports of two patients. Read More »
